Journal Guide

Platelets is an international, fully peer-reviewed journal covering all aspects of platelet-related research. The Journal publishes original articles, review articles and correspondence on blood platelets and platelet-related areas with a view to providing a focus for new information on all aspects of this important blood component.Platelets provides the opportunity for contributors and readers from all scientific several disciplines to engage with progress on platelet function, biochemistry, signal transduction, pharmacology and therapeutics, interaction with other cells in the blood vessel wall, and the contribution of platelets and platelet-derived products to health and disease.From September 2009, in addition to the usual reviews and research articles, there is a new Methods section. This will become a unique feature of Platelets. With the growing complexity and enormous range of different methodologies involved in research on platelets, coupled with increasing utility of new technologies, we envisage that this section will be of huge benefit to platelet researchers worldwide. This should not only improve standardization between laboratories but provide up-to-date and detailed descriptions of both old and new methods that are often difficult to replicate and may thus help to resolve controversies in the field.*© Thomson ISI Journal Citation Reports® 2012.

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published. Papers are accepted on a worldwide basis.Editorial Office:Radiotherapy and Oncology Secretariat, Professor Jens Overgaard, M.D., Danish Cancer Society, Department of Experimental and Clinical Oncology, Aarhus University Hospital, Building 5, Norrebrogade 44, DK 8000 Aarhus C, DENMARK (Tel: +45 89 49 26 29; Fax: +45 86 19 71 09; email: ro@oncology.dk).

A major multidisciplinary journal on vascular diseasesStraddling the crossroads where many disciplines meet, STV takes a new look at vascular and thrombotic diseases and provides every reader with an essential supplement to his or her speciality.STV, which brings together the most up-to-date concepts in biology and clinical subjects, plays a special role in training and informing practitioners in all the relevant fields.The online version of Sang Thrombose Vaisseaux is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.

Seminars in Hematology is a topical journal that focuses on subjects of current importance in clinical hematology and related fields. The journal is devoted to making the present status of such topics and the results of new investigations readily available to the practicing physician. Seminars in Hematology is of special interest to hematologists, oncologists, internal medicine specialists, blood bankers and specialists in thrombosis and hemostasis.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Oncology brings you current, authoritative, and practical reviews of developments in the diagnosis and management of patients with cancer. Each issue examines a single topic of clinical importance. You're guided through each cancer's biology, epidemiology, and pathophysiology, its clinical presentation and therapeutic options, and appropriate follow-up measures. This journal makes an excellent addition to every oncology practice.2013 Topics: Volume 40The Evolving Landscape of Neuroendocrine TumorsEmily K. BergslandCardio-oncology: The Relationships Between the Heart and CancerMarc L. SchwartzProstate CancerLeonard Gomella, Adam Dicker, and William Kevin KellyRenal CancerBrian I. Rini and Thomas PowlesMultiple MyelomaAndrzej J. JakubowiakLung CancerDavid CarboneBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. It offers an informed perspective on today's pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques.

SHOCK; is the only journal exclusively devoted to the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. SHOCK; is dedicated to meeting the present and future information needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.For more information, visit www.shockjournal.org.

STEM CELLS, a peer-reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.

STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cell research including embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

Stem Cells and Development focuses on stem cells of all tissue types and their potential therapeutic applications. The Journal continues its tradition of providing a forum for animated discussion of contentious issues in conventional medicine.Stem Cells and Development covers: Controversial issues on stem cell research Stem cells of all tissues and organs Embryogenesis and adult counterparts of this process Physical processes linking stem cells, primary cell function, and structural development Transition from genes to physical effects: hypotheses and data Development of vasculature, CNS, and other germ layer development and defects Processes included in development: how the molecules work Pluripotentiality of adult stem cells The role of various mediators and how genetic factors affect development at a physical level Correspondence and concise, comprehensive reviews.

The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice.

The Lancet Haematology builds onThe Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.

Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/haematology for more information.

Therapeutic Apheresis and Dialysis is the official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy. The Journal publishes original articles, editorial comments, review articles, case reports, meeting abstracts and Communications information on apheresis and dialysis technologies and treatments.

Thrombosis Journal is ready to receive manuscripts on all aspects of clinical and basic research in the different areas of thrombosis.

Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. Rapid communication and high visibility is facilitated by on-line submission, processing, and dissemination through Science Direct with powerful on-line links to other journals and sources.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Thrombosis and Haemostasis publishes reports on basic, translational and clinical research dedicated to novel results and highest quality in any area of thrombosis and haemostasis, vascular biology and medicine, inflammation and infection, platelet and leukocyte biology, from genetic, molecular & cellular studies, diagnostic, therapeutic & preventative studies to high-level translational and clinical research. Thrombosis and Haemostasis provides position and guideline papers, state-of-the-art papers, expert analysis and commentaries, and dedicated Theme issues covering recent developments and key topics in the field. Thrombosis and Haemostasis provides a forum for the exchange of ideas and concepts fostering cross-disciplinary insights in basic and clinical research.

Transfusion is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, Transfusion reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, Transfusion also presents submissions concerning tissue transplantation and hematopoietic, cellular, and gene therapies.

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology. In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews. Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.